2-Hydroxyethyl 2-methylprop-2-enoate;2-methylidenebutanoic acid;methyl 2-methylprop-2-enoate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2-Hydroxyethyl 2-methylprop-2-enoate;2-methylidenebutanoic acid;methyl 2-methylprop-2-enoate
• 化学式: C16H26O7
• 分子量: 330.37
• InChiKey: WBZPVMYQIKVLTO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.87
• 重原子数：
  23
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  110
• 氢给体数：
  2
• 氢受体数：
  7

文献信息

• Copper (I) complexes with glycine, pyruvate, and succinate
  申请人：C LAB PHARMA INTERNATIONAL, S.A.

  公开号：US10596193B2

  公开（公告）日：2020-03-24

  The present invention is directed to a pharmaceutical and/or dietary supplement composition comprising an effective amount of a copper (I) complex with glycine, pyruvate, or succinic acid and methods of treating mitochondrial, neuromuscular, and other diseases. Also provided are pharmaceutical treatment regimes and kits comprising a copper (I) complex with glycine, pyruvate, or succinate.

  本发明涉及一种药物和/或膳食补充剂组合物，该组合物包含有效量的铜（I）与甘氨酸、丙酮酸或琥珀酸的复合物，以及治疗线粒体、神经肌肉和其他疾病的方法。还提供了包含铜 (I) 与甘氨酸、丙酮酸或琥珀酸的复合物的药物治疗方案和试剂盒。
• [EN] COPPER (I) COMPLEXES WITH GLYCINE, PYRUVATE, AND SUCCINATE<br/>[FR] COMPLEXES DE CUIVRE (I) AVEC DE LA GLYCINE, DU PYRUVATE ET DU SUCCINATE
  申请人：C LAB PHARMA INTERNATIONAL S A

  公开号：WO2014138589A9

  公开（公告）日：2014-12-24
• COPPER (I) COMPLEXES WITH GLYCINE, PYRUVATE, AND SUCCINATE
  申请人：C Lab Pharma International, S.A.

  公开号：EP2964216A2

  公开（公告）日：2016-01-13
• THERAPIES FOR PREVENTING OR SUPPRESSING CLOSTRIDIUM DIFFICILE INFECTION
  申请人：Shone Clifford

  公开号：US20130004561A1

  公开（公告）日：2013-01-03

  The present invention provides an antibody composition comprising ovine antibodies, for use in the prevention or treatment of C. difficile infection wherein the antibodies bind to a C. difficile toxin, and wherein said prevention or treatment is by oral delivery of the antibody composition. Also provided is a pharmaceutical composition of ovine antibodies for oral delivery, which further comprises one or more means for protecting the antibodies from trypsin and/or chymotrypsin and/or stomach acid.
• US8921529B2
  申请人：——

  公开号：US8921529B2

  公开（公告）日：2014-12-30